1Rosenhlum SB, Huynh T, Afonso A, et al. Disoovery of 1-(4-fluropheny1 )-( 3R )-[ 3- (4-fluorophenyl) -3 S-hydroxypropy1 ]-(4S )-(4-hydroxypropy1 )-2-azetidinone ( SCH 58235 ) : a designed, potent,orally active inhibitor of cholesterol absorption [ J ]. J Med Chem,1998, 41(6) :973 - 980. 被引量：1
2Rudel LL. Preclinical and clinical pharmacology of a new class of lipid management agents[J]. Am J Manag Care, 2002, 8(2 Suppl) :S33 - S37. 被引量：1
3Landmesser U, Bahlmann F, Mueller M, et al. Simvastatin versus ezetimibe: pleiotropic and lipid-lowering effects on endothelial function in humans[J]. Circulation, 2005, 111(18):2356-2363. 被引量：1
4Davis HR Jr, Zhu I J, Hoos LM, et al. Niemann-Piek C1 like 1(NPC1L1) is the intestinal phytosterol and cholesterol transporter and a key modulator of whole-body cholesterol homeostasis [ J ]. J Biol Chem, 2004, 279(32) :33586 - 33592. 被引量：1
5Smart EJ, De Rose RA, Father SA. Annexin-2-caveolin 1 complex is a target of ezetimibe and regulates intestinal cholesterol transport[J].Proc Natl Acad Sci USA, 2004, 101 (10) : 3450 - 3455. 被引量：1
6Valasek MA, Weng J, Shaul PW, et al. Caveolin-1 is not required for murine intestinal cholesterol transport [ J ]. J Biol Chem, 2005,280(30) :28103 - 28109. 被引量：1
7Frick W, Bauer-Schafer A, Bauer J, et al. Synthesis of a biotintagged photoaffinity probe of 2-azetidinone cholesterol absorption inhibitors[J]. Bioorg Med Chem, 2003, 11(8) :1639- 1642. 被引量：1
8Kramer W, Girbig F, Corsiero D, et al. Aminopeptidase N (CD13)is a molecular target of the cholesterol absorption inhibitor ezetimibe in the enterocyte brush border membrane[J]. J Biol Chem, 2005,280(2) : 1306 - 1320. 被引量：1
9Harry RD Jr, Douglas SC, Lizbeth H, et al. Ezetimibe, a potent cholesterol absorption inhibitor, inhibits the development of atherosclerosis in apoE knockout mice arteriosclerosis [ J ]. Thromb Vasc Biol, 2001, 21:2032 - 2038. 被引量：1
10Davis HR Jr, Ptda KK, Alton KB, et al. The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor,ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs [ J ]. Metabolism, 2001, 50 (10) :1234- 1241. 被引量：1
